menu
    • menu
    [{"orgOrder":0,"company":"Neolys","sponsor":"Centre Fran\u00e7ois Baclesse | Centre Hospitalier Universitaire de Caen | Institut de canc\u00e9rologie Strasbourg Europe | Centre Oscar Lambret","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"FRANCE","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Oncology","graph2":"Undisclosed","graph3":"Neolys","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Neolys \/ Centre Fran\u00e7ois Baclesse | Centre Hospitalier Universitaire de Caen | Institut de canc\u00e9rologie Strasbourg Europe | Centre Oscar Lambret","highestDevelopmentStatusID":"1","companyTruncated":"Neolys \/ Centre Fran\u00e7ois Baclesse | Centre Hospitalier Universitaire de Caen | Institut de canc\u00e9rologie Strasbourg Europe | Centre Oscar Lambret"}]

    Find Clinical Drug Pipeline Developments & Deals by Neolys

    Menu

    Neolys

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Neolys

                            France arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            Neolys

                            France arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Oncology

                            Study Phase : Undisclosed

                            Sponsor : Centre François Baclesse | Centre Hospitalier Universitaire de Caen | Institut de cancérologie Strasbourg Europe | Centre Oscar Lambret

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Integrative Molecular Analysis of Individual Radiosensitivity in Pediatric Oncology

                            Details : This drug candidate is currently being evaluated in clinical studies for the treatment of Neoplasms.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            September 13, 2023

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Oncology

                            Highest Development Status : Undisclosed

                            Sponsor : Centre François Baclesse | Centre Hospitalier Universitaire de Caen | Institut de cancérologie Strasbourg Europe | Centre Oscar Lambret

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth